A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
More than 120,000 people with cancer come to Mayo Clinic each year. They find experts with extensive experience in the diagnosis and treatment of virtually every kind of cancer and the resources to provide excellent care tailored to their needs. Mayo Clinic doctors and researchers solve the most serious and complex medical questions, one person at a time.
Jacksonville, Florida Clinical Trial Location
Mayo Clinic Cancer Center
4500 San Pablo Rd S,
Jacksonville, FL 32224